Merck & Co., Inc: all 2,453 studies
Page 12 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)CompletedNCT00863109Results posted
- Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)TerminatedNCT00860535Phase 1Results posted
- Phase I Study of MK-0683 in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-098)CompletedNCT00858234Phase 1Results posted
- MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED)CompletedNCT00857311Phase 1Results posted
- ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)TerminatedNCT00856024Results posted
- An Observational Study of Fungal Biomarkers (MK-0000-089)CompletedNCT00854607Results posted
- Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)CompletedNCT00851643Phase 1Results posted
- A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)CompletedNCT00849680Phase 1Results posted
- A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)CompletedNCT00848718Phase 1Results posted
- Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)CompletedNCT00848484Phase 2Results posted
- A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)CompletedNCT00847197Phase 2Results posted
- A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)TerminatedNCT00846391Phase 2Results posted
- Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED)CompletedNCT00845065Phase 3Results posted
- Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)CompletedNCT00845000Phase 1Results posted
- Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)CompletedNCT00844805Phase 3Results posted
- A Study of ProQuad™ in Healthy Children in Korea (V221-023)TerminatedNCT00839917Phase 3Results posted
- MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)CompletedNCT00837577Phase 3Results posted
- Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)TerminatedNCT00836927Phase 2Results posted
- A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)TerminatedNCT00836498Phase 1Results posted
- A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)CompletedNCT00835380Phase 3Results posted
- Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)CompletedNCT00834106Phase 3Results posted
- Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)TerminatedNCT00833053Phase 3Results posted
- ALPHA Sitagliptin Add on to Metformin (0431-103)CompletedNCT00833027Phase 4Results posted
- The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)TerminatedNCT00832624Phase 4Results posted
- Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)CompletedNCT00832390Phase 4Results posted
- COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED)CompletedNCT00832377Phase 2Results posted
- A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)TerminatedNCT00830791Phase 1Results posted
- A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)CompletedNCT00830076Phase 1Results posted
- A Study of the Effects of Single Dose Corticosteroids on Response to AllergensCompletedNCT00828061Phase 1Results posted
- A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)CompletedNCT00827918Phase 2Results posted
- Efficacy and Safety of 4.0 mg/kg Sugammadex at 1-2 PTC in Chinese and European Subjects (Study 19.4.335)(P05775AM1)(COMPLETED)CompletedNCT00826176Phase 3Results posted
- Comparison of 2.0 mg/kg Sugammadex and Neostigmine at Reappearance of T2 in Chinese and European Subjects (Study 19.4.324)(P05768AM1)(COMPLETED)CompletedNCT00825812Phase 3Results posted
- A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)CompletedNCT00824616Phase 2Results posted
- Safety and Immunogenicity Study of V710 Lyophilized Formulation (V710-004)CompletedNCT00822757Phase 1Results posted
- Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)CompletedNCT00822237Phase 3Results posted
- A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal WomenCompletedNCT00820664Phase 1Results posted
- A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)CompletedNCT00819039Phase 1Results posted
- Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)CompletedNCT00818272Results posted
- A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)TerminatedNCT00818259Phase 1Results posted
- Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)CompletedNCT00818168Results posted
- A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss VolumeCompletedNCT00816023Phase 2Results posted
- A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)CompletedNCT00813995Phase 3Results posted
- Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)CompletedNCT00811928Phase 3Results posted
- Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)CompletedNCT00811642Phase 3Results posted
- Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve SubjectsCompletedNCT00807001Phase 1/2Results posted
- Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)TerminatedNCT00806585Phase 2Results posted
- Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)CompletedNCT00804843Phase 2Results posted
- A Study to Evaluate Biomarkers in Patients With Solid Tumors (0000-097)(COMPLETED)CompletedNCT00800865Phase 1Results posted
- A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)CompletedNCT00799708Phase 1Results posted
- MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)TerminatedNCT00797667Phase 2Results posted
- A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)CompletedNCT00792935Phase 2Results posted
- Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)CompletedNCT00792298Phase 2Results posted
- MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)CompletedNCT00791661Phase 1Results posted
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245 (8245-004)(COMPLETED)CompletedNCT00790556Phase 1Results posted
- Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)CompletedNCT00790205Phase 3Results posted
- A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)CompletedNCT00789321Phase 1Results posted
- A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)CompletedNCT00782418Phase 1Results posted
- Assessment of Long-Term Infliximab for Psoriasis (P05319)CompletedNCT00779675Results posted
- A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)CompletedNCT00779584Phase 1Results posted
- Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)TerminatedNCT00779285Phase 4Results posted
- Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)CompletedNCT00778869Phase 4Results posted
- A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)CompletedNCT00777608Phase 1Results posted
- Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)CompletedNCT00773838Phase 2Results posted
- Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)CompletedNCT00773747Phase 3Results posted
- A Study to Evaluate the Effect of Analgesics on a Walking Model of Knee Pain (0000-105)(COMPLETED)CompletedNCT00772967Phase 1Results posted
- Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)CompletedNCT00771472Phase 1Results posted
- Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)TerminatedNCT00771316Phase 3Results posted
- A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)CompletedNCT00770341Phase 3Results posted
- A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)CompletedNCT00769132Phase 1Results posted
- A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)CompletedNCT00768521Phase 1Results posted
- Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)TerminatedNCT00767000Phase 2Results posted
- A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)CompletedNCT00764946Phase 3Results posted
- Trial Investigating the Efficacy and Safety of SCH 900435 (Org 25935) in Relapse Prevention in Participants With Alcohol Dependence (P05718)TerminatedNCT00764660Phase 2Results posted
- 5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2)CompletedNCT00761735Phase 3Results posted
- Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure InfectionsCompletedNCT00761215Phase 2Results posted
- A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013)CompletedNCT00759785Phase 1Results posted
- Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)CompletedNCT00759109Phase 3Results posted
- A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)CompletedNCT00758836Phase 2Results posted
- A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)TerminatedNCT00758680Phase 1Results posted
- Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)CompletedNCT00758485Phase 3Results posted
- Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)CompletedNCT00758069Phase 2Results posted
- A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)CompletedNCT00757601Phase 1Results posted
- Remicade® Crohn's Disease Registry Across Canada (Study P02793)TerminatedNCT00755937Results posted
- MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).CompletedNCT00754130Phase 1Results posted
- A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)CompletedNCT00753415Phase 1Results posted
- Treatment With Infliximab in a Medical Setting (Study P05587)TerminatedNCT00752622Phase 4Results posted
- Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Participants Undergoing Short Surgical Procedures (19.4.319)(P05700 AM2)(COMPLETED)CompletedNCT00751179Phase 3Results posted
- Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)TerminatedNCT00750919Phase 3Results posted
- Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)CompletedNCT00749684Results posted
- Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)CompletedNCT00749398Results posted
- Remicade Safety Line (Study P03236)(COMPLETED)CompletedNCT00748826Results posted
- A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)CompletedNCT00746694Results posted
- A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)CompletedNCT00746512Phase 1Results posted
- A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)TerminatedNCT00745823Phase 3Results posted
- Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)CompletedNCT00743431Results posted
- A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)CompletedNCT00741104Results posted
- A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)CompletedNCT00736333Results posted
- Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)CompletedNCT00736242Results posted
- V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)CompletedNCT00735839Phase 1Results posted
- A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)CompletedNCT00732875Phase 3Results posted